The Latest Breaking News from Food and Drug Administration

The U.S. Food and Drug Administration on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.

The Food and Drug Administration approved two genetic treatments for sickle cell disease, including one that uses gene-editing. The approvals offer hope for patients and signal a new medical era.

Here’s a guide to what consumers need to know about the first daily oral contraceptive that will be available for sale without a prescription.

The Food and Drug Administration’s July 13, 2023, approval of the first over-the-counter birth control pill, called Opill, broadens the options for people seeking to prevent pregnancy. When Opill becomes available, presumably in the first quarter of 2024, it will be sold in grocery and convenience stores, in pharmacies and…

A recent Food and Drug Administration rule requires healthcare providers to notify people if they have dense breasts. Studies have shown that dense breast tissue can make it more difficult to detect breast cancer early.

The number of electronic cigarette devices sold in the U.S. has nearly tripled to over 9,000, despite a three-year effort by the Food and Drug Administration to crack down on kid-friendly flavors

The number of different e-cigarette devices sold in the U.S. has nearly tripled to over 9,000, despite a three-year effort by the Food and Drug Administration to crack down on kid-friendly flavors

The U.S. Food and Drug Administration has approved the first gene therapy to treat a deadly form of muscular dystrophy

Since its founding in 2016, Elon Musk’s neurotechnology company Neuralink has had the ambitious mission to build a next-generation brain implant with at least 100 times more brain connections than devices currently approved by the US Food and Drug Administration (FDA).